Anti-MUC17 Antibody is a humanized monoclonal antibody expressed in CHO cells targeting the transmembrane mucin MUC17 (also known as MUC3G). This product specifically recognizes the extracellular domain of MUC17. MUC17 is overexpressed in various gastrointestinal tumors, particularly gastric and colorectal cancers. The antibody binds to MUC17 on the cell surface, mediating antibody-dependent cellular cytotoxicity (ADCC), and serves as a vehicle for the targeted delivery of conjugated therapeutic payloads (as in ADC research) into tumor cells.